Kimo

KIMO

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Kimo, Inc. is a small clinical-stage biopharmaceutical company focused on developing drugs to treat cancer. Its main work centers on a drug called upifitamab rilsodotin, which is designed to target certain types of ovarian cancer. The company's customers are ultimately cancer patients, and its products are aimed at oncologists and hospitals in the medical market.

Kimo makes no product revenue yet because its drugs are still being tested in clinical trials. The company is based in the United States and funds its operations through cash reserves and potential future partnerships or licensing deals. Its competitive position depends almost entirely on whether its lead drug candidate succeeds in clinical trials and earns approval from the FDA — if trials fail or approval is denied, the company faces serious financial risk since it has no other approved products generating income.

Winston Score History

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

N/A

no trend

Data not available

Operating Margin

N/A

no trend

Data not available

ROCE

N/A

no trend

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

N/A

no trend

Data not available

EPS YoY

N/A

no trend

Data not available

EPS Consistency

N/A

no trend

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

no trend

Data not available

FCF Margin

N/A

no trend

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

no trend

Data not available

Interest Cover

N/A

no trend

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/A

no trend

Data not available

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial